Not Tagged
Not Tagged
['crpc']
 highlights: 1) phi-ii dual-psma targeting with alpha mab ac-j591 + lu-psma (n=18) mcrpc after &gt;1 arpi 2/6 dlts at 40 kbq/kg ac-j591 w/50% w/psa50 decline, 2) phi car-t w/psca marker in #mcrpc &gt;1 arpi (n=14) no dlts w/100m + cytoxan 300mg/m2 feasible #asco23 
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope